About NeoBiotechnologies
Licensing as well as developing new Hybridoma Clones secreting monoclonal antibodies to a wide variety of human proteins with an ultimate goal to cover the entire human proteome. Antibody products are available for various applications through our OEM-partners. Presently, NeoBiotechnologies is holding more than 1,000 hybridomas.
Sectors
- antibodies
- proteins
- custom services